Delivery Order SPE2DB22D1017-SPE2DB24FG0WV

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.29 delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialized medication used for diabetes management. The contract has a firm fixed price pricing type and a period of performance through November 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.12 fixed-price delivery order is for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,461.42 Firm Fixed Price Delivery Order covers the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used to manage diabetes. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,565.72 Firm Fixed Price Delivery Order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medical products. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,767.02 firm-fixed-price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.32 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of August 31, 2022 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $5,213.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication for diabetes management. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999.00 and runs through...
This federal contract award, valued at $2,313.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,730.56 firm fixed-price delivery order contract is for the supply of VICTOZA 3-pak 18 mg/3 ml pens. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,914.72 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medical product used for diabetes management. The contract has an ultimate completion date of June 30, 2022 and is a firm fixed-price agreement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG0WV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,912.23 firm fixed-price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a prescription medication used for the treatment of diabetes.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has no set-aside designation, indicating open competition.

Generated 5/17/25, 10:15 AM